首页> 外文期刊>Archives of Animal Nutrition >In vitro and in vivo degradation of myo-inositol hexakisphosphate by a phytase from Citrobacter braakii
【24h】

In vitro and in vivo degradation of myo-inositol hexakisphosphate by a phytase from Citrobacter braakii

机译:来自巴西柠檬酸杆菌的肌醇六磷酸酶体外和体内降解肌醇六磷酸

获取原文
获取原文并翻译 | 示例
           

摘要

Phytases (EC 3.1.3) are widely used in animal feed to increase the availability of phosphorus and decrease the anti nutritive effect of myo-inositol hexakisphosphate (InsP6). The aim of this work was to investigate the stereospecific degradation of InsP6 in vitro and in vivo by a phytase from Citrobacter braakii (C. braakii), and to study gastric survival of the phytase as well as the site of action in the gastrointestinal tract. The in vitro results showed that the C. braakii phytase belongs to the group of 6-phytases (EC 3.1.3.26). However, in approximately one out of 10 instances the phytase initiated hydrolysis at the D-3 (L-1) position, demonstrating that phytase specificity is not unambiguous. Following the main degradation pathway, InsP6 was degraded by stepwise removal of the phosphate groups on positions 6/1/5. The stereospecificity was found to be similar under in vitro and in vivo conditions. The phytase was found to be stable in the gastric environment and to be active in the stomach and possibly also in the proximal small intestine. While InsP4 was accumulated under in vitro conditions this was not the case in vivo, where both InsP5 and InsP4 were seen to be hydrolysed in the small intestine, possibly as a combined action of the C. braakii phytase and endogenous phosphatases present in the mucosa. The ability of the C. braakii phytase to focus its activity on degrading InsP6 to InsP4 is believed to be a favourable complement to the endogenous phosphatases.View full textDownload full textKeywords Citrobacter braakii , degradation, inositol phosphates, in vitro , in vivo , phytase, phytate, pigsRelated var addthis_config = { ui_cobrand: "Taylor & Francis Online", services_compact: "citeulike,netvibes,twitter,technorati,delicious,linkedin,facebook,stumbleupon,digg,google,more", pubid: "ra-4dff56cd6bb1830b" }; var addthis_config = {"data_track_addressbar":true,"ui_click":true}; Add to shortlist Link Permalink http://dx.doi.org/10.1080/1745039X.2012.735082
机译:肌醇六磷酸酶(EC 3.1.3)被广泛用于动物饲料中,以增加磷的利用率并降低肌醇六磷酸(InsP 6 )的抗营养作用。这项工作的目的是研究Bracii(C. braakii)植酸酶在体内和体外对InsP 6 的立体定向降解,并研究该植酸酶的胃存活以及在胃肠道的作用部位。体外结果表明,布拉克梭菌肌醇六磷酸酶属于6-肌醇六磷酸酶(EC 3.1.3.26)。但是,在大约十分之一的情况下,植酸酶会在D-3(L-1)位置引发水解反应,这表明植酸酶的特异性并不明确。遵循主要降解途径,InsP 6 通过逐步去除6/1/5位上的磷酸酯基而降解。发现在体外和体内条件下立体特异性相似。发现肌醇六磷酸酶在胃环境中是稳定的,并且在胃中并且可能在近端小肠中也有活性。尽管InsP 4 在体外条件下积累,但体内情况并非如此,InsP 5 和InsP 4 均被水解。在小肠中,可能是由于布拉氏梭菌肌醇六磷酸酶和粘膜中存在的内源性磷酸酶的共同作用。人们认为,巴西炭疽菌植酸酶将其活性集中在将InsP 6 降解为InsP 4 的能力是对内源性磷酸酶的有利补充。查看全文下载全文Braakii柠檬酸杆菌,降解,肌醇磷酸盐,体外,体内,植酸酶,植酸盐,猪相关变量,digg,google,more“,发布号:” ra-4dff56cd6bb1830b“}; var addthis_config = {“ data_track_addressbar”:true,“ ui_click”:true};添加到候选列表链接永久链接http://dx.doi.org/10.1080/1745039X.2012.735082

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号